Remove Biobanking Remove Genome Project Remove Medicine Remove Scientist
article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines.

Genome 127
article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. In April 2003, after its launch in October 1990, the project was completed, generating the first sequence of the human genome.

Genome 98
article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

The same is becoming true for the healthcare industry, and one of the first major breakthroughs in the area was the 100,000 Genomes Project. The information gathered from the project is still providing insights today, a decade later. Scientists are able to study the aggregated, de-identified genetics of these individuals.